Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA provides notice to proceed with phase I study of HDT-301 RNA COVID-19 vaccine

July 2, 2021

Topline phase II data for VAL-083 in patients with recurrent GBM

July 2, 2021

I-Mab provides updates for its 4-1BB bispecific antibody portfolio

July 2, 2021

PRO-C18L may predict response to liver fibrosis treatment

July 2, 2021

VRP-034: A nephroprotective SMC complex of polymyxin B for Gram-negative infections

July 2, 2021

ETX-0462: a promising global Gram-negative antimicrobial agent

July 2, 2021

New GTPase KRAS G12C mutant inhibitors discovered at Beta Pharma

July 2, 2021

Neurocrine Biosciences presents new muscarinic M4 receptor antagonists

July 2, 2021

Omeros discovers mannan-binding lectin serine protease 2 inhibitors

July 2, 2021

Incyte presents new fibroblast growth factor receptor inhibitors

July 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...